These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24504594)

  • 41. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Kayal M; Tixier E; Plietz M; Radcliffe M; Rizvi A; Riggs A; Trivedi P; Khaitov S; Sylla P; Greenstein A; Dubinsky MC; Grinspan A
    Inflamm Intest Dis; 2020 Jun; 5(2):59-64. PubMed ID: 32596255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
    Kistangari G; Lopez R; Shen B
    Inflamm Bowel Dis; 2017 Apr; 23(4):661-671. PubMed ID: 28296825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
    Mikamo H; Kondo T; Okuyama K; Marcella SW; Ruzicka DJ
    Anaerobe; 2020 Feb; 61():102139. PubMed ID: 31830597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).
    Vehreschild MJGT; Taori S; Goldenberg SD; Thalhammer F; Bouza E; van Oene J; Wetherill G; Georgopali A
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2097-2106. PubMed ID: 30099637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
    Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postoperative antimicrobials after lung transplantation and the development of multidrug-resistant bacterial and Clostridium difficile infections: an analysis of 500 non-cystic fibrosis lung transplant patients.
    Whiddon AR; Dawson KL; Fuentes A; Perez KK; Peterson LE; Kaleekal T
    Clin Transplant; 2016 Jul; 30(7):767-73. PubMed ID: 27091109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
    Coukos JA; Howard LA; Weinberg JM; Becker JM; Stucchi AF; Farraye FA
    Dig Dis Sci; 2012 Jun; 57(6):1544-53. PubMed ID: 22311367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 56. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk Factors for Primary
    Davies K; Lawrence J; Berry C; Davis G; Yu H; Cai B; Gonzalez E; Prantner I; Kurcz A; Macovei I; Pituch H; Nováková E; Nyč O; Gärtner B; Berger FK; Oleastro M; Cornely OA; Vehreschild MJGT; Pedneault L; Wilcox M
    Front Public Health; 2020; 8():293. PubMed ID: 32766196
    [No Abstract]   [Full Text] [Related]  

  • 58. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 59. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of long-term outcomes of S and J pouches and continent ileostomies in ulcerative colitis patients with restorative proctocolectomy-experience in subspecialty pouch center.
    Mukewar S; Wu X; Lopez R; Shen B
    J Crohns Colitis; 2014 Oct; 8(10):1227-36. PubMed ID: 24657364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.